Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aptus PharmaBOM:544529 -1.98%18 PS Ratio is 10.10 as of Aug. 11, 2026, which is 71% above its 10-year median of 5.91. GuruFocus rates BOM:544529 with a GF Score™ of 18/100. The stock has 6 warning signs investors should review. Among 118 Medical Distribution companies, Aptus Pharma ranks worse than 96.61% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Aptus Pharma's share price is ₹274.25.
Aptus Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹27.17. Hence, Aptus Pharma's PS Ratio for today is 10.10.
The historical rank and industry rank for Aptus Pharma's PS Ratio or its related term are showing as below:
BOM:544529'
s PS Ratio Range Over the Past 10 Years
Min: 2.32 Med: 5.91 Max: 10.3
Current: 10.1
During the past 4 years, Aptus Pharma's highest PS Ratio was 10.30. The lowest was 2.32. And the median was 5.91.
BOM:544529's PS Ratio is ranked worse than 96.61% of 118
companies
in the Medical Distribution industry
Industry Median: 0.39
vs BOM:544529: 10.10
During the past 12 months, the average Revenue per Share Growth Rate of Aptus Pharma was 119.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 57.00% per year.
During the past 4 years, Aptus Pharma's highest 3-Year average Revenue per Share Growth Rate was 57.00% per year. The lowest was 57.00% per year. And the median was 57.00% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Aptus Pharma PS Ratio Related Terms
Aptus Pharma PS Ratio Historical Data
* Premium members only.
The historical data trend for Aptus Pharma's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Aptus Pharma's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aptus Pharma PS Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Aptus Pharma's PS Ratio distribution charts can be found below:
* The bar in red indicates where Aptus Pharma's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Aptus Pharma's PS Ratio for today is calculated as
Aptus Pharma's Share Price of today is ₹274.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aptus Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹27.17.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Aptus Pharma (BOM:544529) has a PS Ratio of 10.10 as of Aug. 11, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Aptus Pharma and its competitors. This is 71% above median its historical median of 5.91. Over the past decade, Aptus Pharma's PS Ratio has ranged from 2.32 to 10.30. According to the industry distribution chart, Aptus Pharma ranks #114 out of 118 companies in the Medical Distribution industry, placing it in the top 96.6%.
Is Aptus Pharma's PS Ratio too high?
Aptus Pharma's current PS Ratio of 10.10 is 71% above median its 10-year median of 5.91. Over the past 10 years, this metric has ranged from a low of 2.32 to a high of 10.30. The Medical Distribution industry median PS Ratio is 0.39. Aptus Pharma's value of 10.10 is 2489.7% above this industry median. Based on the distribution chart, Aptus Pharma ranks #114 out of 118 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Aptus Pharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Aptus Pharma's PS Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Aptus Pharma ranks #114 out of 118 companies for PS Ratio. This places Aptus Pharma in the lower half of its industry. The industry median PS Ratio is 0.39. Aptus Pharma's value of 10.10 is 2489.7% above this benchmark. Historically, Aptus Pharma's own PS Ratio has ranged from 2.32 to 10.30 over the past decade. While the company's 10-year median is 5.91 vs. the industry median of 0.39, Aptus Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.39, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aptus Pharma's current PS Ratio of 10.10 is 2489.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Aptus Pharma and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aptus Pharma's current PS Ratio is 10.10, which is 71% above median its own 10-year median of 5.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptus Pharma stock overvalued right now?
Aptus Pharma (BOM:544529) has a current PS Ratio of 10.10. The current PS Ratio is 10.10, which is 71% above median its 10-year median of 5.91 and 2489.7% above the Medical Distribution industry median of 0.39. Aptus Pharma's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Aptus Pharma (BOM:544529), the current PS Ratio is 10.10 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations. It operates through a contract manufacturing model. The group provides a diverse range of pharmaceutical products catering to various therapeutic categories, including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.
18GF Score
Get the complete analysis for BOM:544529
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544529 has been successfully added to your 
